average weight loss in 3 months on semaglutide TrimRX Weight Change With Semaglutide

Common side effects include nausea, reduced appetite, and gastrointestinal symptoms

That distinction remains a major point of debate among clinicians, regulators, and pharmaceutical manufacturers

Eligibility is primarily based on BMI, though this is not the only consideration

Preclinical studies in rodents consistently show reduced alcohol intake with GLP-1 medications, but human clinical trials have produced mixed results

As semaglutide moves into generic territory, the firm Novo Nordisk may show waning interest in research into indication expansions, or how the drug works in genetically diverse populations or on its implementation in poorer countries where no patent is held

Product and Segment Trends Market segmentation highlights strong demand concentration in convenient and high-functionality formats: Ready-to-drink shakes (31.0%) lead due to convenience and zero-preparation use High-protein positioning (34.0%) dominates nutritional focus as consumers prioritize muscle preservation and satiety Powder meal replacements remain popular for flexible dosing and affordability Digestive-support and micronutrient-fortified products are gaining traction Clinical, wellness, and DTC channels are expanding rapidly alongside traditional retail Structured nutrition formats are becoming increasingly important as consumers seek predictable and easier daily nutrition solutions